PUBLICATIONS
Références et publications
Tous les liens de cette page renvoient vers des résumés d’articles (abstracts). L’ensemble des versions intégrales sont disponibles au Centre de Psychiatrie Interventionnelle.
Psychiatrie interventionnelle en Suisse
Société Suisse de Psychiatrie Interventionnelle (SSPI)
Autres spécialistes : Dr Fady Rachid (Genève, TMS) · Dr Michael Fischer (Zürich, TMS et autres techniques)
DEXDexmédétomidine, dépression et anxiété▼
Dexmedetomidine in the Treatment of Depression: An Up-to-date Narrative Review.
(PubMed)
Antidepressant effects of dexmedetomidine compared with ECT in patients with treatment-resistant depression.
(PubMed)
Anesthetics as Treatments for Depression: Clinical Insights and Underlying Mechanisms.
(PubMed)
Dexmedetomidine in Psychiatry: Repurposing of its Fast-Acting Anxiolytic, Analgesic and Sleep Modulating Properties.
(PubMed)
N₂OProtoxyde d’azote et dépression▼
Nitrous oxide for the treatment of psychiatric disorders: A systematic review of the clinical trial landscape
(PubMed)
The evolution of NMDA receptor antagonists as antidepressant agents.
(PubMed)
Nitrous Oxide Reduced Suicidal Ideation in Treatment-Resistant Major Depression in Exploratory Analysis.
(PubMed)
The efficacy and tolerability of inhaled nitrous oxide in major depressive disorder: a systematic review and meta‑analysis.
(PubMed)
Mini-Review: A Brief History of Nitrous Oxide (N2O) Use in Neuropsychiatry.
(PubMed)
Exploring Nitrous Oxide as Treatment of Mood Disorders: Basic Concepts.
(PubMed)
Nitrous Oxide: an emerging novel treatment for treatment-resistant depression.
(PubMed)
Safety and efficacy of an equimolar mixture of oxygen and nitrous oxide: a randomized controlled trial in patients with peripheral neuropathic pain.
(PubMed)
A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression.
(PubMed)
Le gaz hilarant serait redoutablement efficace pour soigner la
(Caminteresse)
dépre
(Caminteresse)
ssion
(Caminteresse)
TMSInformations générales sur la TMS▼
tms-therapie.ch
(Tms-therapie)
TMSEfficacité et sécurité de la TMS▼
Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). (Clinical Neurophysiology
(Ncbi)
Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines.
(DOI)
Clinical Neurophysiology
(DOI)
TMSEfficacité de la TMS dans la dépression▼
The Clinical TMS Society Consensus Review and Treatment Recommendations for TMS Therapy for Major Depressive Disorder.
(Ncbi)
Repetitive transcranial magnetic stimulation for depression, NICE interventional procedure guidance [IPG542]. (National Institute for Health and Care Excellence)
(Nice)
Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial.
(Ncbi)
Comparative efficacy and acceptability of neuromodulation procedures in the treatment of treatment-resistant depression: a network meta-analysis of randomized controlled trials.
(DOI)
Transcranial magnetic stimulation for geriatric depression: Promises and pitfalls
(Ncbi)
Intensive HF-rTMS treatment in refractory medication-resistant unipolar depressed patients. (Journal of Affective Disorders)
(Ncbi)
TMSEfficacité de la TMS dans d’autres indications▼
Transcranial magnetic stimulation of dorsolateral prefrontal cortex reduces cocaine use: A pilot study
(Ncbi)
Repetitive transcranial magnetic stimulation in chronic pain: a review of the literature.
(Ncbi)
Long-term maintenance of the analgesic effects of transcranial magnetic stimulation in fibromyalgia.
(Ncbi)
Review of the effectiveness of transcranial magnetic stimulation for post-traumatic stress disorder.
(Ncbi)
An Update of the Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in Patients with Obsessive Compulsive Disorder
(Jneuropsychiatry)
Repetitive transcranial magnetic stimulation for obsessive-compulsive disorder: A systematic review and pairwise/network meta-analysis.
(DOI)
A pilot study of fMRI targeted rTMS for obsessive compulsive disorder.
(DOI)
Repetitive Transcranial Magnetic Stimulation Treatment for Chronic Tinnitus: A Randomized Clinical Trial.
(Lien)
Repetitive Transcranial Magnetic Stimulation for Phantom Limb Pain in Land Mine Victims: A Double-Blinded, Randomized, Sham-Controlled Trial.
(Ncbi)
Brain Stimulation in Alzheimer’s Disease. (Frontiers in Psychiatry)
(Ncbi)
Repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer’s disease.
(Ncbi)
Neuromodulation for the treatment of eating disorders and obesity.
(Ncbi)
ECTEfficacité de l’ECT dans la dépression▼
Le renouveau des électrochocs
(Wp)
Antidepressant pharmacotherapy failure and response to subsequent electroconvulsive therapy: a meta-analysis.
(Ncbi)
Relapse Following Successful Electroconvulsive Therapy For Major Depression: A Meta- Analysis
(Ncbi)
Maintenance electroconvulsive therapy up to 12 years.
(Ncbi)
Speed of remission in elderly patients with depression: electroconvulsive therapy v. medication.
(Ncbi)
Electroconvulsive Therapy in the Elderly: New Findings in Geriatric Depression.
(Ncbi)
Improvements in Health-Related Quality of Life With Electroconvulsive Therapy – A Meta-analysis.
(Ncbi)
ECTEct et trouble bipolaire▼
Treatment-Resistant Bipolar Depression: A Randomized Controlled Trial of Electroconvulsive Therapy Versus Algorithm-Based Pharmacological Treatment.
(Ncbi)
Electroconvulsive therapy in bipolar depression – effectiveness and prognostic factors Treatment.
(Ncbi)
What happens to the course of bipolar disorder after electroconvulsive therapy?
(Ncbi)
ECTEct et schizophrénie▼
ECT in schizophrenia: a review of the evidence.
(Ncbi)
Electroconvulsive Therapy and Schizophrenia – A Systematic Review
(Ncbi)
Augmentation of Antipsychotics with Electroconvulsive Therapy in Treatment-Resistant Schizophrenia Patients with Dominant Negative Symptoms: A Pilot Study of Effectiveness.
(Ncbi)
Electroconvulsive therapy in ultra-resistant schizophrenia – A case series.
(Ncbi)
Clinical Effectiveness of Maintenance Electroconvulsive Therapy in Patients with Schizophrenia: A retrospective Cohort Study
(Ncbi)
ECTEct : securité, mécanismes, effets secondaires▼
Neuropathological evaluation of an 84-year-old man after 422 ECT treatments.
(Ncbi)
Electroconvulsive therapy increases temporal gray matter volume and cortical thickness.
(Ncbi)
Objective Cognitive Performance Associated with Electroconvulsive Therapy for Depression: A Systematic Review and Meta-Analysis.
(Ncbi)
Evaluation of cumulative cognitive deficits from electroconvulsive therapy.
(Ncbi)
An Examination of Mortality and Other Adverse Events Related to Electroconvulsive Therapy Using a National Adverse Event Report System.
(Ncbi)
Neurotransmitters and Electroconvulsive Therapy.
(Ncbi)
Hippocampal Neurogenesis and Antidepressive Therapy: Shocking Relations.
(Ncbi)
Grey matter volume increase following electroconvulsive therapy in patients with late life depression: a longitudinal MRI study.
(Ncbi)
Effect of electroconvulsive therapy on gray matter volume in major depressive disorder.
(Ncbi)
Mechanisms of Antidepressant Response to Electroconvulsive Therapy Studied With Perfusion Magnetic Resonance Imaging.
(Ncbi)
Neuromodulation in response to electroconvulsive therapy in schizophrenia and major depression.
(Ncbi)
Long-Term Cognitive and Psychological Functioning in Post–Electroconvulsive Therapy Patients.
(Ncbi)
Electroconvulsive therapy and risk of dementia in patients with affective disorders – a cohort study.
(Ncbi)
ECT : une thérapeutique essentielle en psychiatrie.
(DOI)
KETKétamine et dépression▼
Combined ketamine and psychotherapy provide no additional benefit beyond ketamine alone in treating depression or PTSD: Evidence from a help-seeking sample.
(DOI)
Identification of an optimal dose of intravenous ketamine for late-life treatment-resistant depression: a Bayesian adaptive randomization trial.
(DOI)
A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression.
(Ncbi)
Low-dose ketamine for treatment resistant depression in an academic clinical practice setting
(PubMed)
Kétamine comme option thérapeutique
(Medicalforum)
How club drug ketamine fights depression
(Nature)
ave drug holds promise for treating depression fast
(Nature)
ketamine: stimulating antidepressant treatment?
(Bjpo)
Ketamine for treatment-resistant depression: recent developments and clinical applications.
(Ncbi)
NMDAR inhibition-independent antidepressant actions of ketamine metabolites.
(Ncbi)
Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion.
(Ncbi)
Administration of ketamine for unipolar and bipolar depression
(Ncbi)
Efficacy, Safety, and Durability of Repeated Ketamine Infusions for Comorbid Posttraumatic Stress Disorder and Treatment-Resistant Depression. (Journal of Clinical Psychiatry)
(Ncbi)
Rapid effectiveness of intravenous ketamine for ultraresistant depression in a clinical setting and evidence for baseline anhedonia and bipolarity.
(Ncbi)
Evaluation of the Trajectory of Depression Severity With Ketamine and Esketamine Treatment in a Clinical Setting.
(PubMed)
Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis.
(Ncbi)
KETKétamine dans d’autres indications▼
Efficacy and safety of ketamine in the management of anxiety and anxiety spectrum disorders – a review of the literature.
(Ncbi)
Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder – proof-of-concept
(Ncbi)
Rapid Resolution of Obsessions After an Infusion of Intravenous Ketamine in a Patient with Treatment-Resistant Obsessive-Compulsive Disorder – A Case Report.
(Ncbi)
Ketamine’s dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders.
(Ncbi)
Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial.
(Ncbi)
A/VAudio & vidéo▼
The Psychedelic Revolution – Don’t Forget About Ketamine
(YouTube)
TMS en psychiatrie – AP-HM mag flash, Assistance Publique-Hôpitaux de Marseille
(YouTube)
TMS Brain Stimulation Can Help Combat Depression, Beth Israel Deaconess Medical Center, Boston
(YouTube)
AVC – Les thérapeutiques par Stimulation Magnétique Transcrânienne, Institut du Cerveau et de la Moelle épinière
(YouTube)
Ketamine for Treatment-Refractory Depression – Video Interview with James Murrough, MD
(YouTube)
Des électrochocs contre la dépression. Emission 36,9° du 10.05.2017
(Avisdexperts)
L’électricité pour lutter contre la dépression. Emission CQFD du 30.08.2018, RTS La 1ère
(Pages)
Dépression, de l’ombre à la lumière. Emission Temps Présent du 06.12.2018, RTS1
(Pages)
La kétamine sur le devant de la scène pour traiter les dépressions résistantes. Le 19H30 du 13.07.2019, RTS1
(Rts)
Le retour en grâce de la neurostimulation en psychiatrie. Swissinfo.ch, 01.05.2025
(Swissinfo)